Crinetics Pharmaceuticals, Inc. (CRNX) Monday announced the appointment of Tobin Schilke as chief financial officer, effective February 28, 2025.
Schilke, with over 25 years of global pharmaceutical experience, had worked in several biotech companies, and most recently was with Revance Therapeutics as chief financial officer.
On March 10, 2025, Crinetics, a clinical stage pharmaceutical company, expects to grant Schilke 52,000 restricted stock units and a stock option to purchase 80,000 shares of common stock.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.